The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
T helper cells that produce interleukin 17 (IL-17) are associated with inflammation and the control of certain bacteria. We report here the essential involvement of the adaptor protein Act1 in IL-17 receptor (IL-17R) signaling and IL-17-dependent immune responses. After stimulation with IL-17, recruitment of Act1 to IL-17R required the IL-17R conserved cytoplasmic 'SEFIR' domain, followed by recruitment of the kinase TAK1 and E3 ubiquitin ligase TRAF6, which mediate 'downstream' activation of transcription factor NF-kappaB. IL-17-induced expression of inflammation-related genes was abolished in Act1-deficient primary astroglial and gut epithelial cells. This reduction was associated with much less inflammatory disease in vivo in both autoimmune encephalomyelitis and dextran sodium sulfate-induced colitis. Our data show that Act1 is essential in IL-17-dependent signaling in autoimmune and inflammatory disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The initial event in IL-17R signaling is recruitment of Act1 (aka CIKS), a multifunctional signaling protein that also contains a SEFIR domain necessary for IL-17R-Act1 association”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
In the citing paper
“upon IL-17 signaling, Act1 rapidly recruits and ubiquitinates TNF-receptor associated factor (TRAF)6”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
In the citing paper
“Act1 is best understood as a nonredundant activator of IL-17RA-dependent signals”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
In the citing paper
“TRAF6 also promotes activation of MAPK/AP1 pathways and the C/EBPβ and δ transcription factors”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Qian et al., 2007
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Interleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372
Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.519 · Cited by 1,521 · cited 1×
“Because IL-17 has a critical function in neutrophilia through the upregulation of chemokines, which is important for the development of inflammatory diseases including coliti”
BackgroundDong, Y., & Benveniste, E. N. (2001) · Glia · doi:10.1002/glia.1107 · Cited by 1,293 · cited 1×
“Because astrocytes are responsive to IL-17 and are important in the production of cytokines and chemokines during EA”
BackgroundTRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
Lomaga, M. A., Yeh, W.-C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,267
Research works printed but not linked: 13
- Mangan, P.R. et al. Transforming growth factor-β induces development of the TH17 lineage. Nature 441, 231–234 (2006). · DOI · Paper page
- Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467–476 (2004). · DOI · Paper page
- Novatchkova, M., Leibbrandt, A., Werzowa, J., Neubuser, A. & Eisenhaber, F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem. Sci. 28, 226–229 (2003). · DOI · Paper page
- Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005). · DOI · Paper page
- Iwakura, Y. & Ishigame, H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 116, 1218–1222 (2006). · DOI · Paper page
- Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467–476 (2004). · DOI · Paper page
- Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005). · DOI · Paper page
- Weaver, A. et al. An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J. 19, 1668–1670 (2005). · DOI · Paper page
- Becher, B., Bechmann, I. & Greter, M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J. Mol. Med. 84, 532–543 (2006). · DOI · Paper page
- Gold, R., Linington, C. & Lassmann, H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953–1971 (2006). · DOI · Paper page
- Koenders, M.I. et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum. 52, 3239–3247 (2005). · DOI · Paper page
- Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005). · DOI · Paper page
- Han, Y., Wang, J., Zhou, Z. & Ransohoff, R.M. TGFβ1 selectively up-regulates CCR1 expression in primary murine astrocytes. Glia 30, 1–10 (2000). · DOI · Paper page
Cited by
Items 301–400 of 623
Pisitkun, P., Claudio, E., Ren, N., Wang, H., & Siebenlist, U. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27653 · Cited by 36
Lisak, R. P., Benjamins, J. A., Bealmear, B., Nedelkoska, L., Yao, B., Land, S., & Studzinski, D. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-30 · Cited by 36
“Liu Y, Teige I, Birnir B, Issazadeh-Navikas S: Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE.”
InfluentialUpdate on the role of Interleukin 17 in rheumatologic autoimmune diseases
Konya, C., Paz, Z., Apostolidis, S. A., & Tsokos, G. C. (2015) · Cytokine · doi:10.1016/j.cyto.2015.01.003 · Cited by 35
Role of astrocytes in sleep deprivation: accomplices, resisters, or bystanders?
Que, M., Li, Y., Wang, X., Zhan, G., Luo, X., & Zhou, Z. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1188306 · Cited by 37
“, 2012) by facilitating the activation and translocation of NF-κB into the nucleus (Qian et al., 2007).”
BackgroundZhang, C., Weng, Y., Wang, H., Zhan, S., Li, C., Zheng, D., & Qi, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112953 · Cited by 35
Du, S., Li, Z., Xie, X., Xu, C., Shen, X., Wang, N., & Shen, Y. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12840 · Cited by 39
Wang, S., Kuai, Y., Lin, S., Li, L., Gu, Q., Zhang, X., Li, X., He, Y., Chen, S., Xia, X., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02791-0 · Cited by 37
Self-citationArtificial macrocycles as IL-17A/IL-17RA antagonists
Wang, W., Groves, M. R., & Dömling, A. S. S. (2018) · MedChemComm · doi:10.1039/c7md00464h · Cited by 34
Systematic analysis of the IL ‐17 receptor signalosome reveals a robust regulatory feedback loop
Draberova, H., Janusova, S., Knizkova, D., Semberova, T., Pribikova, M., Ujevic, A., Harant, K., Knapkova, S., Hrdinka, M., Fanfani, V., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104202 · Cited by 35
“First, we observed that cells deficient in ACT1, the very proximal IL-17R-interacting protein (Chang et al , 2006; Qian et al , 2007), show completely disrupted IL-17RSC formation (Fig 4A and Table EV4) and disabled the activation of TBK1 and IKK e upon IL-17 stimulation (Fig EV4A).”
Goepfert, A., Barske, C., Lehmann, S., Wirth, E., Willemsen, J., Gudjonsson, J. E., Ward, N. L., Sarkar, M. K., Hemmig, R., Kolbinger, F., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111489 · Cited by 40
“While IL-17 signaling does not involve any DDcontaining proteins, the SEFIR domain plays a similar role as the TIR domain in mediating the initial, membrane-proximal recruitment of the multifunctional adaptor protein, Act1, through SEFIR-SEFIR interactions (Chang et al., 2006; Qian et al., 2007).”
A Role for the Cytoplasmic Adaptor Protein Act1 in Mediating IL-17 Signaling
Lindén, A. (2007) · Science's STKE · doi:10.1126/stke.3982007re4 · Cited by 35
Pappu, B. P., Angkasekwinai, P., & Dong, C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.12.003 · Cited by 38
“It was further confirmed, using Act1-deficient mice, that IL-17-mediated inflammatory responses are indeed severely impaired in these mice (Qian et al., 2007).”
BackgroundRahman, P., & Elder, J. T. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111242 · Cited by 34
Chen, W., Wen, C., Wang, M., Xiao, Z., Zhang, Z., Chun-lan, W., & Wu, R. (2023) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12683 · Cited by 33
“Transcription factor NF-κB activator 1 (ACT1) was found to contain a SEFIR domain which is recruited by IL-17R and mediates the IL-17R-ACT1 interaction.(25) ACT1 contains two tumor TRAF binding motifs, which binds to its downstream effector TRAF6 to activate TAK1.”
BackgroundAn Astroglial Basis of Major Depressive Disorder: Molecular, Cellular, and Circuit Features
Lu, C., Ren, J., & Cao, X. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.07.017 · Cited by 37
Du, J., Rybak, D., Su, Q., Wang, Q., Yuan, Q., Gao, J., Wang, Y., Nakielski, P., Wang, X., Pierini, F., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202501242 · Cited by 36
Self-citationMatsushima, Y., Kikkawa, Y., Takada, T., Matsuoka, K., Seki, Y., Yoshida, H., Minegishi, Y., Karasuyama, H., & Yonekawa, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900694 · Cited by 36
“Th17 cells are a novel subset of CD4+ T cells that are regulated by TGF-b, IL-6, and IL-23.”
BackgroundInfluentialTRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis
Sakamuri, S. S. V. P., Valente, A. J., Siddesha, J. M., Delafontaine, P., Siebenlist, U. K., Gardner, J. D., & Chandrasekar, B. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.03.038 · Cited by 34
Pharmacological Treatment for Neuroinflammation in Stress-Related Disorder
Lee, D.-H., Lee, J., Hong, D.-Y., Lee, E.-C., Park, S.-W., Lee, Y. K., & Oh, J. S. (2022) · Biomedicines · doi:10.3390/biomedicines10102518 · Cited by 34
“Nuclear translocation of NF-κB in astrocytes was associated with TNF-α, IL-1β, 1L-17, ROS, Toll-like receptor (TLR), and other factors related to CNS inflammation [31,32].”
BackgroundThe Role of Interleukin-17 in Juvenile Idiopathic Arthritis: From Pathogenesis to Treatment
Paroli, M., Spadea, L., Caccavale, R., Spadea, L., Paroli, M. P., & Nante, N. (2022) · Medicina · doi:10.3390/medicina58111552 · Cited by 39
Zepp, J. A., Wu, L., Wen, Q., Ouyang, W., Aronica, M. A., ERZURUM, S. C., & Li, X. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402647 · Cited by 33
“Work from our group and others has shown that the adaptor protein known as activator of NF-kB-1 (ACT1), or CIKS, harbors a SEFIR domain and is a key component in IL-17A and IL-25 signaling (4, 12, 18, 19).”
BackgroundMethodSelf-citationMarks, B. R., & Craft, J. E. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.03.001 · Cited by 36
“Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D, et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.”
BackgroundHamilton, T., Li, X., Novotny, M., Pavicic, P. G., Datta, S., Zhao, C., Hartupee, J., & Sun, D. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0811404 · Cited by 32
“It is noteworthy, however, that the Act1/TRAF6 interaction is not disrupted by the IKK deficiency.”
BackgroundInfluentialSelf-citationIntracellular DAMPs in Neurodegeneration and Their Role in Clinical Therapeutics
Kaur, J., Singh, H., & Naqvi, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03289-9 · Cited by 33
“Tropomyosin receptor kinase B and IL-17 are the transmembrane receptors upregulated by the astrocytes in neuroinflammation conditions, and as a result, pro-inflammatory cytokines are produced when IL-17 binds to its receptors which recruits the nuclear factor ĸB (NF-ĸB) activator 1 (Act1) [38].”
BackgroundXiang, Q., Chen, L., Hou, S., Fang, J., Zhou, Y. N., Bai, L., Liu, Y., Kijlstra, A., & Yang, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084214 · Cited by 32
“TRAF5 and Act1, encoded by the TRAF3IP2 gene, have been implicated in the control of immune and inflammatory responses [44,45,46].”
BackgroundFunction of Act1 in IL-17 Family Signaling and Autoimmunity
Wu, L., Zepp, J. A., & Li, X. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0106-3_13 · Cited by 36
Self-citationIL-17 in the Rheumatologist’s Line of Sight
Truchetet, M., Mossalayi, M. D., & Boniface, K. (2013) · BioMed Research International · doi:10.1155/2013/295132 · Cited by 32
“In addition, NFκB activator 1 (Act 1), an adaptor protein for IL-17 receptor, is an essential component of IL-17-mediated signaling and downstream effects [13, 14].”
BackgroundCMTM4 is a subunit of the IL-17 receptor and mediates autoimmune pathology
Knizkova, D., Přibíková, M., Draberova, H., Šemberová, T., Trivić, T., Synackova, A., Ujevic, A., Stefanovic, J., Drobek, A., Huranová, M., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01325-9 · Cited by 34
Act1-ivating IL-17 inflammation
Hunter, C. A. (2007) · Nature Immunology · doi:10.1038/ni0307-232 · Cited by 33
Interleukin-17: Functional and Structural Features, Application as a Therapeutic Target
Kostareva, O. S., Gabdulkhakov, A. G., Kolyadenko, I., Garber, M., & Tishchenko, S. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919140116 · Cited by 36
RKIP mediates autoimmune inflammation by positively regulating IL‐17R signaling
Lin, W., Wang, N., Zhou, K., Su, F., Jiang, Y., Shou, J., Liu, H., Ma, C., Qian, Y., Wang, K., et al. (2018) · EMBO Reports · doi:10.15252/embr.201744951 · Cited by 32
“HeLa cells are epithelial cells and have been widely used to investigate IL-17R signaling pathways [13,30,31].”
Self-citationWu, H., Tsai, L., Huang, C.-K., Hsu, P., Chen, M., Chen, Y. M., Hu, C., Shen, C., Lee, C., Chang, M., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc2823 · Cited by 34
“Among these, the ubiquitin E3 ligase TRIM56 (tripartite motif 56) was of interest because it is known to interact with and mediate K63-linked ubiquitination on stimulator of interferon genes (STING) for the recruitment of TRAF Family Member Associated NF-κB Activator–binding kinase 1 (TBK1) and downstream signaling (3…”
BackgroundLambert, S., Swindell, W. R., Tsoi, L. C., Stoll, S. W., & Elder, J. T. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.12.032 · Cited by 32
“Act1 is recruited to the IL-17 receptor through a SEFIR domain-mediated oligomerization and is essential for appropriate regulation of IL-17emediated signaling (Chang et al., 2006; Qian et al., 2007).”
BackgroundHao, R., Song, Y., Li, R., Wu, Y., Yang, X., Li, X., Qian, F., Ye, R. D., & Sun, L. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00349.2018 · Cited by 35
“As a downstream effector of IL-17RAmediated signaling, ACT1 is necessary for IL-17A-induced activation of NF- B, activator protein 1, and JNK and p38 MAPKs (28).”
BackgroundInfluentialSelf-citationThe Relationship Between Neuroimmunity and Bipolar Disorder: Mechanism and Translational Application
Niu, Z., Yang, L., Wu, X., Zhu, Y., Chen, J., & Fang, Y. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00403-7 · Cited by 32
Karimi, K., Farid, A., Myles, S., & Miar, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-82522-8 · Cited by 33
“The number of detected SNP markers in the current study (62,404) is higher than that (34,816) reported by Cai et al.”
ResultPathak, J. L., Fang, Y., Chen, Y., Ye, Z., Guo, X., Yan, Y., Zha, J., Liang, D., Ke, X., Yang, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.628139 · Cited by 33
“In mouse models of experimental autoimmune encephalomyelitis (EAE) and asthma, the lack of Act1 leads to resistance to IL-17-mediated inflammation (Qian et al., 2007; Kang et al., 2010).”
BackgroundNeuroinflammation: Molecular Mechanisms And Therapeutic Perspectives
Meccariello, R., Marino, M., Mele, E., Pastorino, G. M. G., Operto, F. F., Santoro, A., & Viggiano, A. (2022) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524922666220929153215 · Cited by 30
IL-17 in Peritoneal Dialysis-Associated Inflammation and Angiogenesis: Conclusions and Perspectives
Witowski, J., Kamhieh‐Milz, J., Kawka, E., Catar, R. A., & Jörres, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01694 · Cited by 28
Jiang, R., Xu, J., Zhang, Y., Liu, J., Wang, Y., Chen, M., Chen, X., & Yin, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113010 · Cited by 28
Self-citationThe Differential Regulation of Human ACT1 Isoforms by Hsp90 in IL-17 Signaling
Wu, L., Wang, C., Boisson, B., Misra, S., Rayman, P. A., Finke, J. H., Puel, A., Casanova, J., & Li, X. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400715 · Cited by 29
Self-citationSønder, S. U., Paun, A., Ha, H.-L., Johnson, P. F., & Siebenlist, U. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103233 · Cited by 27
He, R.-R., Wu, S., Gao, R., Chen, J., Peng, Q., Hu, H., Zhu, L., Du, Y., Sun, W., Ma, X., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001223 · Cited by 29
Li, Y., Huang, Y., Cai, J. X., Jiang, D., Jian, J., Lu, Y., & Wang, B. (2022) · Journal of Fish Diseases · doi:10.1111/jfd.13674 · Cited by 28
Self-citationThe miR-30a Negatively Regulates IL-17-Mediated Signal Transduction by Targeting Traf3ip2
Wan, Q., Zhou, Z. L., Ding, S., & He, J. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0146 · Cited by 27
MicroRNAs and other mechanisms regulate interleukin-17 cytokines and receptors
Yang, X. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e474 · Cited by 30
Mountz, J. D., Wang, J. H., Xie, S., & Hsu, H. (2011) · PubMed · Cited by 30
Interleukin-17 contributes to cardiovascular diseases
Ding, H., Yang, J., Ding, J., DING, J.-W., Chen, P., & Zhu, P. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1580-5 · Cited by 30
Could the inhibition of IL-17 or IL-18 be a potential therapeutic opportunity for gastric cancer?
Nguyen, P. M., & Putoczki, T. L. (2018) · Cytokine · doi:10.1016/j.cyto.2018.01.008 · Cited by 28
Novel therapeutic targets along the Th17 pathway
Ouyang, W., Filvaroff, E. H., Hu, Y., & Grogan, J. L. (2009) · European Journal of Immunology · doi:10.1002/eji.200839105 · Cited by 27
Song, H., Song, T., Yang, T., Sun, C., He, B., Li, H., Wang, Y., Li, Y., Wu, H., Hu, Y.-M., et al. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.303039 · Cited by 26
“For example, astrocytes upregulate the interleukin (IL)-17 receptor and recruit nuclear factor-κB activator 1 to form a signaling complex, which facilitates the production of pro-inflammatory cytokines, chemokines, and metalloproteinases during neuroinflammation (Qian et al., 2007).”
Ho, A. W., Garg, A. V., Monin, L., Simpson-Abelson, M. R., Kinner, L. B., & Gaffen, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070168 · Cited by 26
Pathogenetic Overview of Psoriatic Disease
Haroon, M., & FitzGerald, O. (2012) · Journal of Rheumatology Supplement · doi:10.3899/jrheum.120232 · Cited by 25
IL-17R signaling: new players get in on the Act1
May, M. J. (2011) · Nature Immunology · doi:10.1038/ni.2093 · Cited by 25
Manjunath, Y., Yoshida, T., Valente, A. J., Kandikattu, H. K., Sakamuri, S. S. V. P., Siddesha, J. M., Sukhanov, S., Saifudeen, Z. R., Ma, L., Siebenlist, U. K., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.724138 · Cited by 26
Dexmedetomidine mitigate acute lung injury by inhibiting IL-17-induced inflammatory reaction
Zhang, Y., Jia, S., Gao, T., Zhang, R., Liu, Z., & Wang, Y. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.10.017 · Cited by 25
Chronic Mucocutaneous Candidiasis in an Adolescent Boy Due to a Novel Mutation in TRAF3IP2
Bhattad, S., Dinakar, C., Pinnamaraju, H., Ganapathy, A., & Mannan, A. U. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00664-x · Cited by 25
“17R [7]; this will likely result in loss-of-function.”
In Vitro Th17-Polarized Human CD4+ T Cells Exacerbate Xenogeneic Graft-versus-Host Disease
Delens, L., Ehx, G., Somja, J., Vrancken, L., Belle, L., Seidel, L., Grégoire, C., Fransolet, G., Ritacco, C., Hannon, M., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.10.007 · Cited by 26
IκB-ζ Expression Requires Both TYK2/STAT3 Activity and IL-17–Regulated mRNA Stabilization
Muromoto, R., Tawa, K., Ohgakiuchi, Y., Sato, A., Saino, Y., Hirashima, K., Minoguchi, H., Kitai, Y., Kashiwakura, J., Shimoda, K., et al. (2019) · ImmunoHorizons · doi:10.4049/immunohorizons.1900023 · Cited by 27
“An IL-17 signaling adaptor protein, ACT1 (encoded by TRAF3IP2) (51), has been shown to mediate IL-17–induced upregulation of IkB-z mRNA in keratinocytes (17), although it is unclear whether ACT1 is required for IkB-z 3ʹUTR-mediated mRNA stabilization in IL-17–treated cells.”
BackgroundBijelić, D. D., Milicevic, K. D., Lazarević, M. N., Miljković, D. M., Pristov, J. B., Savić, D. Z., Petković, B. B., Anđjus, P. R., Momčilović, M. B., & Nikolic, L. M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24699 · Cited by 25
“In EAE, immune cell-derived inflammatory mediators have been shown to induce profound changes in the expression of inflammation-associated genes in astrocytes (Mayo et al., 2016; Prajeeth et al., 2017; Qian et al., 2007).”
Background14-3-3ζ–TRAF5 axis governs interleukin-17A signaling
McGowan, J., Peter, C., Kim, J. P., Popli, S., Veerman, B., Saul‐McBeth, J., Conti, H. R., Pruett‐Miller, S. M., Chattopadhyay, S., & Chakravarti, R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008214117 · Cited by 24
Niu, J., Guo, Y., Jing, G., Wang, H., Yang, L., Li, Y., Gao, Y., Wang, H., Li, A., Xu, X., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202305042 · Cited by 27
Self-citationCommon variants of ZNF750, RPTOR and TRAF3IP2 genes and psoriasis risk
Dębniak, T., Soczawa, E., Boer, M., Różewicka-Czabańska, M., Wiśniewska, J., Serrano‐Fernández, P., Mirecka, A., Paszkowska‐Szczur, K., Lubiński, J., Krysztoforska, L., et al. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1407-9 · Cited by 25
“The protein product of TRAF3IP2 gene, Act 1, binds with interleukin 17 receptor and is essential for IL17dependent signaling in autoimmune and inflammatory disease, including psoriasis [12, 20].”
BackgroundLife before seventeen: cloning of the IL-17 receptor
Gaffen, S. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102576 · Cited by 22
“Proof that Act1 was indeed essential for IL-17R signaling soon followed with studies of EAE and IL-17 signaling in Act1 mice (16, 17).”
BackgroundPanagiotidis, G., Vásquez‐Pacheco, E., Chu, X., Seeger, W., Agha, E. E., Bellusci, S., & Lingampally, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1609509 · Cited by 25
Contribution of Interleukin-17A to Retinal Degenerative Diseases
Zhong, H., & Sun, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.847937 · Cited by 25
How to enhance MSCs therapeutic properties? An insight on potentiation methods
García-Guerrero, C., Fuentes, P., Araya, M. J., Djouad, F., Luz‐Crawford, P., Vega-Letter, A. M., & Altamirano, C. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03935-6 · Cited by 25
“To initiate this effect mediated by IL-17, the cytokine binds to an IL-17RA/IL-17RC receptor located on the cell membrane [69].”
BackgroundSabat, R., Witte, E., Witte, K., & Wolk, K. (2012) · Springer eBooks · doi:10.1007/978-3-0348-0522-3_2 · Cited by 23
“Afterward, TAK1 kinase (TGFb-activated kinase 1) and the E3 ubiquitin ligase TRAF6 (TNFR-associated factor 6) are recruited to the IL-17 receptor complex followed by NFkB and C/EBPb/d activation [95–97].”
BackgroundRyzhakov, G., Blazek, K. D., & Udalova, I. A. (2011) · Journal of Molecular Evolution · doi:10.1007/s00239-011-9450-7 · Cited by 23
“Mammalian SEFIR-domain containing proteins, IL-17R and Act1/CIKS, have received a lot of attention from immunologists because of their crucial functions in anti-bacterial immunity and involvement in autoimmune diseases (Huang et al. 2007; Qian et al. 2007).”
BackgroundBmi1 Regulates IκBα Degradation via Association with the SCF Complex
Okuyama, Y., Tanaka, Y., Jiang, J., Kamimura, D., Nakamura, A., Ota, M., Ohki, T., Higo, D., Ogura, H., Ishii, N., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701223 · Cited by 29
“We found that the stimulation of BC1 cells with IL-17 alone weakly induced the production of IL-6, an NF-kB target molecule (Fig.”
BackgroundResultInfluentialOh, S., Shim, M., Son, M., Jang, J. T., Son, K. H., & Byun, K. (2021) · Antioxidants · doi:10.3390/antiox10020298 · Cited by 24
“For NF-κB activation, IL-17RA associates with an adaptor protein, nuclear factor-kappa B activator 1 (ACT1)/ tumor necrosis factor receptor-associated factor 3 interacting protein 2 (TRAF3IP2) [15,16], and TNF receptor-associated factor 6 (TRAF6) [14].”
BackgroundAutoimmunity in psoriatic arthritis: pathophysiological and clinical aspects
Emmungil, H., İlgen, U., & Di̇reskeneli̇, H. (2021) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2011-235 · Cited by 22
“Mice lacking TRAF3IP2 develop Sjögren’s syndrome in association with lupus nephritis due to hyper-B cell function but contrarily they show delayed and less severe experimental autoimmune encephalomyelitis which was thought to be IL-17 mediated [97].”
BackgroundA two phase regulation of bone regeneration: IL-17F mediates osteoblastogenesis via C/EBP-β in vitro
Wang, Y., Kim, J., Chan, A., Whyne, C. M., & Nam, D. (2018) · Bone · doi:10.1016/j.bone.2018.07.007 · Cited by 25
Dynamic evolution of CIKS (TRAF3IP2/Act1) in metazoans
Wu, B., Jin, M., Gong, J., Du, X., & Bai, Z. (2011) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2011.03.027 · Cited by 21
Sun, H., Zhong, D., Jin, J., Liu, Q., Wang, H., & Li, G. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.10.046 · Cited by 21
Grunewald, Z. I., Ramirez‐Perez, F. I., Woodford, M. L., Morales‐Quinones, M., Mejia, S., Manrique‐Acevedo, C., Siebenlist, U. K., Martinez‐Lemus, L. A., Chandrasekar, B., & Padilla, J. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15262 · Cited by 21
Satyam, S. M., & Bairy, L. K. (2022) · Nutrients · doi:10.3390/nu14153029 · Cited by 21
“NF-kB activator 1 (Act1) may be attracted to IL-17 receptors and pro-inflammatory cytokines may be produced as a result [34].”
BackgroundA Novel Nuclear Function for the Interleukin-17 Signaling Adaptor Protein Act1
Velichko, S., Zhou, X., Zhu, L., Anderson, J. D., Wu, R., & Chen, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163323 · Cited by 21
“It was subsequently shown that Act1 could bind to several IL-17 receptor family members, via homotypic interactions between their respective SEFIR domains [16, 22].”
BackgroundsiRNA-Act1 Inhibits the Function of IL-17 on Lung Fibroblasts via the NF-κB Pathway
Dong, Z., Yang, Y., Zhang, T., Li, Y., Kang, Q., Lei, W., Cao, Y., Niu, X., Wang, D., & Tai, W. (2013) · Respiration · doi:10.1159/000348403 · Cited by 23
Urabe, S., Isomoto, H., Ishida, T., Maeda, K., Inamine, T., Kondo, S., Higuchi, N., Sato, K., Uehara, R., Yajima, H., et al. (2015) · BioMed Research International · doi:10.1155/2015/416838 · Cited by 21
“It is known that (1) downstream signal transduction molecules, including I-κB and NF-κB, are shared by the IL-17 and TNF-α signaling pathways [8–10], (2) IL-17R knock-out mice are protected from inflammatory diseases including CD [27], and (3) TRAF3IP2-deficient mice are protected against dextran sodium sulfate-induce…”
BackgroundTRAF6 Promotes Gastric Cancer Cell Self-Renewal, Proliferation, and Migration
Yang, M., Jin, M., Li, K., Liu, H., Yang, X., Zhang, X., Zhang, B., Gong, A., & Bie, Q. (2020) · Stem Cells International · doi:10.1155/2020/3296192 · Cited by 20
Hidradenitis Suppurativa: An Understanding of Genetic Factors and Treatment
Chu, Y.-L., & Yu, S. (2024) · Biomedicines · doi:10.3390/biomedicines12020338 · Cited by 22
“After binding to ligands, IL-17R acts on the Act 1 adaptor protein (Act1) to induce the ubiquitination of TNF receptor-associated factor 6 (TRAF6) [48,49].”
Role and functional mechanisms of IL‑17/IL‑17R signaling in pancreatic cancer (Review)
Liu, W., Wang, X., & Wu, W. (2024) · Oncology Reports · doi:10.3892/or.2024.8803 · Cited by 22
“During this process, the NF‑ κ B activator 1, Act1, is recruited downstream of the IL‑17R complex upon recognizing the SEFIR domain, thereby relaying IL‑17‑induced inflammatory response signals (35,36).”
BackgroundInfluentialImmunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo
Abdou, A. G., Maraee, A. H., Yassien, H., & Sarhan, M. (2018) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2018.09.18 · Cited by 20
“Ineterleukin 17 (IL-17) in patients with vitiligo was previously correlated positively with early age of vitiligo onset and may contribute to immune response in early onset disease through activation by a different pathway.(13) IL-17 activates nuclear factor-kB (NF-κB) and mitogen-activated protein kinase pathways.”
BackgroundZhou, C., Wu, D., Jawale, C. V., Li, Y., Biswas, P. S., McGeachy, M. J., & Gaffen, S. L. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155715 · Cited by 24
Li, H., Zhou, Z., Tai, W., Feng, W.-Y., Zhang, D., Gu, X., & Yang, R. (2015) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029615618022 · Cited by 20
“Number of patients 165 149 Gender (Male: female) 58:107 46:103 Age at diagnosis median (range), year 29 (2-79) Child-onset ITP (age at diagnosis<18) 49 Adult-onset ITP (age at diagnosis 18) 116 Disease course median (range), month 12 (0.”
BackgroundT-Lymphocyte Interactions with the Neurovascular Unit: Implications in Intracerebral Hemorrhage
Shi, S. X.-Y., Vodovoz, S. J., Xiu, Y., Liu, N., Jiang, Y., Katakam, P. V. G., Bix, G. J., Dumont, A. S., & Wang, X. (2022) · Cells · doi:10.3390/cells11132011 · Cited by 22
“Astrocytes can be activated by any of these cytokines, which translocate its transcription factor NF-kB to shift towards a pro-inflammatory state where they further promote inflammation in ICH [20,30].”
BackgroundYang, Y., Chen, Y., Yu, L., Zhang, X., Shang, J., Fan, J., Zhang, R., Ren, J., & Duan, X. (2022) · Inflammation Research · doi:10.1007/s00011-022-01674-z · Cited by 21
“Moreover, TRAF6 promotes MAPK/AP1 pathway activation and transcription factors C/EBPβ and δ [34, 37, 38, 45] (see Fig.”
BackgroundMoon, H., Kang, C.-S., Choi, J., Choi, D., Choi, H. I., Choi, Y. W., Jeon, S. G., Yoo, J.-Y., Jang, M. H., Gho, Y. S., et al. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.10 · Cited by 19
Ivanov, S., & Lindén, A. (2007) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.1.2.279 · Cited by 19
MicroRNAs and other mechanisms regulate interleukin-17 cytokines and receptors
Mai, J. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/474 · Cited by 19
“A component of the IL-17 receptors that is crucial for IL-17 signaling is an adaptor termed ACT1 (also known as TRAF3IP2; TRAF3 interacting protein 2), which is needed to mediate various downstream event of the IL-17 receptors(31-34).”
BackgroundIL-17 in pancreatic disease: pathogenesis and pharmacotherapy.
Hu, F., Guo, F., Zhu, Y., Zhou, Q., Li, T., Xiang, H., & Shang, D. (2020) · PubMed Central · Cited by 25
The Evolving View of IL-17-Mediated Immunity in Defense Against Mucocutaneous Candidiasis in Humans
Soltész, B., Tóth, B., Sarkadi, A. K., Erdös, M., & Maródi, L. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2015.1049345 · Cited by 19
“Revealing germ-line IL17F, IL17RA and ACT1 mutations in patients with CMCD The binding of IL-17A and IL-17F to their receptors induces diverse signaling pathways and results in the secretion of antimicrobial peptides, tumor necrosis factor (TNF)-α, IL-6, IL-8, CXCL-1, CCL20, granulocyte colony-stimulating factor (GCSF…”
BackgroundInfluentialStructural Insights into the Interleukin-17 Family Cytokines and Their Receptors
Liu, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9367-9_5 · Cited by 20
Goedken, E. R., Argiriadi, M. A., Dietrich, J. D., Petros, A. M., Krishnan, N., Panchal, S. C., Qiu, W., Wu, H., Zhu, H., Adams, A. M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-18760-1 · Cited by 18
Songhet, P., Barthel, M., Röhn, T. A., Maele, L. V., Cayet, D., Sirard, J., Bachmann, M. F., Köpf, M., & Hardt, W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013804 · Cited by 18
“disruption of IL-17RA signaling in enterocytes reduced the pathology of DSS-induced colitis [16] and IL-17A and -F are known to induce enterocyte expression of antimicrobial peptides and numerous pro-inflammatory cytokines.”
BackgroundTICAM-1/TRIF associates with Act1 and suppresses IL-17 receptor–mediated inflammatory responses
Miyashita, Y., Kouwaki, T., Tsukamoto, H., Okamoto, M., Nakamura, K., & Oshiumi, H. (2021) · Life Science Alliance · doi:10.26508/lsa.202101181 · Cited by 18
“…Miyashita et al. https://doi.org/10.26508/lsa.202101181 vol 5 | no 2 | e202101181 2 of 14 IL-17RAandAct1havea commondomain called thesimilar expression to fibroblast growth factor genes and IL-17R (SEFIR) domain, which is essential for the interaction between IL-17RA and Act1 (Qian et al, 2007).”
BackgroundResultInfluentialLiu, J., Liu, S., Cao, H., Shi, B., Li, Q., Shan, J., Yuan, J., & Lin, J. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/6461560 · Cited by 18
Self-citationArray‐CGH study of partial trisomy 9p without mental retardation
Bouhjar, I. B. A., Hannachi, H., Mougou-Zerelli, S., Labalme, A., Gmidène, A., Soyah, N., Missaoui, S., Sanlaville, D., Elghezal, H., & Saâd, A. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34044 · Cited by 17
Moderzynski, K., Heine, L., Rauch, J., Papp, S., Kuehl, S., Richardt, U., Fleischer, B., & Osterloh, A. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005404 · Cited by 19
Metadata
- Authors
- Qian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-wit, D., Xiao, J., Lu, Y., Giltiay, N., Liu, J., Kordula, T., Zhang, Q.-W., Vallance, B., Swaidani, S., Aronica, M., Tuohy, V. K., Hamilton, T., & Li, X.
- Affiliations
- Cleveland Clinic (US)
- Case Western Reserve University (US)
- Virginia Commonwealth University (US)
- University of British Columbia (CA)
- Corresponding author
- Li, Xiaoxia
- ORCID
- Venue
- Nature Immunology
- Published
- 2007-02-04
- Volume
- 8
- Issue
- 3
- Pages
- 247-256
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2021674244
- Cited by
- 614
- References
- 45
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 34 · 2023: 32 · 2022: 37 · 2021: 41 · 2020: 23 · 2019: 30 · 2018: 25 · 2017: 25 · 2016: 21 · 2015: 26 · 2014: 31 · 2013: 38 · 2012: 33
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI065470, AI 065470)
- National Institute of Neurological Disorders and Stroke (R01-NS071996)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- Act1, IL-17, IL-17 receptor signaling, TAK1, TRAF6, NF-κB activation, adaptor proteins, astrocytes, intestinal epithelial cells, autoimmune encephalomyelitis, DSS-induced colitis, inflammatory diseases, T helper cells
- MeSH terms
- Animals, Autoimmune Diseases, Colitis, Encephalomyelitis, Autoimmune, Experimental, Enzyme-Linked Immunosorbent Assay, Female, Fluorescent Antibody Technique, Gene Expression Regulation, HeLa Cells, Humans, Inflammation, T-Lymphocytes, Transfection, Signal Transduction, Autoimmunity, Gene Expression, CD40 Antigens, Adoptive Transfer, Reverse Transcriptase Polymerase Chain Reaction, Interleukin-17, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins, Adaptor Proteins, Signal Transducing, Mice, B-Cell Activation Factor Receptor, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.